Ticker: MR, Company: Mindray Medical International LTD, Type: 6-K, Date: 2012-07-18
Original SEC Filing: Click here
Webplus: MR/20120718/6-K/2_EX-99.1/000.htm SEC Original: d382256dex991.htm
Mindray Medicalmpletes Acquisition of Dragonbios Orthopedics Businessout Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters inShenzhen, China, U.S. headquarters inMahwah, New Jerseyand multipleles offices in major international markets. From our main manufacturing and engineering basehina, we supply through our worldwide distribution network a broad range
Webplus: MR/20120718/6-K/1/000.htm SEC Original: d382256d6k.htm
On July17, 2012, Mindray Medical International Limited (thempany) closed a transaction to acquire 51% of the equity interest of Wuhan Dragonbio Surgical Implant (Dragonbio) for a totalshnsideration of RMB224,376,700 (approximately US$35.5 million). Dragonbio is a domestic medical orthopedic products provider thatecializes in trauma,ine, joint and other surgical products.
Company Information:
Ticker: MR, Company: Mindray Medical International LTD, Type: 6-K, Date: 2012-07-18CIK: 0001373060, Location: F4, SIC: 3841, SIC Desc: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Business Phone & Address:
MINDRAY BUILDING, KEJI 12TH ROAD SOUTH
SHENZHEN 518057
-
- Forum
- Topics
- Last Post
Leave A Comment
You must be logged in to post a comment.